查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1844419

白色生物技术市场按产品类型、技术、应用、最终用户和原料划分－2025-2032年全球预测

White Biotechnology Market by Product Type, Technology, Application, End User, Raw Material - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，白色生物技术市场将成长至 3,015.3 亿美元，复合年增长率为 3.28%。

主要市场统计数据
基准年 2024 2327.8亿美元
预计年份：2025年 2404.5亿美元
预测年份：2032年 3015.3亿美元
复合年增长率 (%) 3.28%

简洁扼要、全面深入地说明不断发展的白人生物技术格局，阐述技术进步、不断变化的监管环境和战略要务。

白色生物技术领域正处于曲折点，技术创新、永续性和不断变化的监管环境在此交汇融合，重塑产业价值链。这种融合代表着多种力量的汇聚，它们正在重新定义生物製程和生物基产品的开发、生产和商业化方式，并影响着各个产业。随着产业相关人员日益重视低碳解决方案和循环经济，发酵、酵素催化和基因工程的角色正从利基应用扩展到主流製造策略。

本简报重点阐述了影响製造商、加工商和终端用户决策的技术进步和不断变化的市场动态。细胞培养和酵素技术的进步提高了製程产量比率，并催生了新的产品类别；下游製程创新则降低了纯化成本，并减少了环境足迹。同时，法律规范和公共采购偏好也提升了永续性资格作为竞争优势的重要性。

引言概述了接下来的关键主题，为更深入的分析奠定了基础，包括技术和政策的变革性转变、关税影响、跨产品和应用类别的见解、区域性能差异，以及为寻求将科学能力转化为商业性优势的领导者提供的实用建议。

分子创新、製程强化与永续性需求如何重塑白色生物技术领域的产业价值炼与商业性重点？

白色生物技术正经历着变革性的转变，这主要得益于分子生物学的快速发展、製程强化以及永续性的迫切需求。合成生物学和基于 CRISPR 的基因编辑技术正在加速客製化微生物和酵素的开发，从而拓展可生产的生化产品种类，并实现更高效的资源利用。因此，各公司正在寻求整合的生物加工平台，将上游发酵、精准的酵素催化作用和精简的下游製程相结合，以缩短开发週期并提高单位经济效益。

同时，需求面的变化正在提升生物基产品在食品、食材和药品领域的价值。买家高度重视产品的可追溯性、生命週期排放的降低以及功能性能达到或超过传统替代品的水平。这些期望正在推动配料生产商、配方商和品牌所有者之间开展跨行业伙伴关係，共同开发具有商业性规模化应用的产品。此外，资本配置模式也正向那些既展现出技术差异化优势又拥有清晰合规路径的公司倾斜，从而推动了产业整合和策略联盟的形成。

总而言之，这些变革性的变化迅速将实验室的突破转化为工业选择，需要采取适应性策略，将科学可能性与供应链韧性和监管现实相协调。

美国关税调整的连锁反应将重塑白色生物技术领域的筹资策略、生产布局和供应链韧性。

美国关税决定为白色生物技术生态系统中的生产商、供应商和买家带来了新的商业性复杂性。预计到2025年，这些决定将产生累积影响，反映在进口成本、供应链筹资策略和定价动态等方面的调整，迫使企业重新评估其采购和生产布局。部分生物基投入品和半成品关税的提高，促使一些企业加快在地化生产倡议，将关键加工环节迁回国内，或探索其他原料来源，以减少对高关税商品的依赖。

因此，拥有灵活製程设计和模组化製造能力的公司能够透过快速调整原料采购来更好地缓解额外的成本压力。下游加工商和合约受託製造公司正面临来自客户的日益增长的本地化服务需求，这些客户优先考虑降低关税风险和确保供应的连续性。同时，采购负责人正在加强供应商资格认证标准，将关税敏感度分析、总到岸成本评估和紧急采购计画纳入其中。

重要的是，关税主导的再平衡也促使相关人员对垂直整合产生兴趣。因此，各公司正在评估能够增强原材料供应韧性、降低物流风险、保护利润率并同时遵守不断变化的贸易和关税制度的策略性投资。

针对特定细分市场的情报，揭示产品类型、加工技术、应用、最终用户和原材料选择如何塑造不同的战略管道。

深入的市场区隔揭示了不同的机会领域，这些领域会影响研发重点和商业性策略，涵盖产品类型、技术、应用、终端用户和原料选择等各个方面。产品层面的细分包括胺基酸、生质燃料、生物製药、生质塑胶、酵素和维生素，其子类别包括L-离胺酸和L-苏氨酸、生物柴油和生质乙醇、单株抗体和重组蛋白、PHA和PLA生质塑胶、工业和特种酵素以及维生素C和维生素E，每个子类别都有其独特的技术和监管考量。这些产品差异会影响下游製程的复杂性、监管管道以及客户接受产品的时间安排。

在技​​术维度上，细胞培养平台、下游分离科学、酶工程和固定化、发酵模式以及包括CRISPR和重组DNA技术在内的基因工程方法之间存在显着差异。每个技术领域都提供了降低成本、提高产量比率和扩展功能的独特途径，企业通常会结合多种技术来建立竞争障碍。基于应用场景的主导的特定要求和性能基准也由此确定。

随着农业、动物饲料、化学製造、化妆品和製药等行业的客户对产品属性的重点各不相同，例如化妆品注重保质期，药品注重监管文件，动物饲料注重营养密度，终端用户正在进一步完善其商业化策略。此外，在木薯、玉米、甘蔗和小麦等原料中进行选择，会影响永续性、供应链风险状况和成本结构，这凸显了製定产品与原料整合计画的必要性，该计画应使技术可行性与商业性需求相符。

全球生物技术中心采用模式、法规环境和营运重点的跨区域综合分析

美洲、欧洲、中东和非洲以及亚太地区的区域动态呈现出不同的招募、产能和政策环境轨迹，每个区域都呈现不同的商业性格局和营运考量。美洲在下游加工创新、创投活动和强劲的机构需求方面具有优势，但同时也存在对原材料的依赖以及对贸易政策的敏感性，这些因素都会影响采购决策。这些动态有利于那些能够将技术差异化与灵活的供应链配置结合的公司。

欧洲、中东和非洲正着力推行更严格的监管、永续性报告和循环经济措施，为生物基材料和更环保的生产流程创造了机会。在该地区营运的生产商和技术供应商必须适应统一的法律规范和日益增长的客户透明度需求，而能够证明其检验生命週期改进和合规准备的企业将获得丰厚的回报。相较之下，亚太地区以规模主导的生产能力、快速成长的国内生物基原料需求以及多元化的原料供给能力为特征，促使企业投资建设大规模发酵基础设施并建立区域伙伴关係，以满足国内和出口需求。

综合来看，这些区域差异表明，成功的公司正在根据当地的监管预期、原料生态系统和客户优先事项来调整其市场进入和成长策略，同时保持灵活性，以便在商业条件变化时在不同区域之间重新部署能力。

竞争动态、合作关係以及现有企业与创新者之间的卓越营运如何塑造白人生物技术领域的领导地位

白色生物技术领域的企业层面动态凸显了成熟产业参与企业、专业生物加工创新者和敏捷新兴企业的多元化组成，这些因素共同决定了竞争的激烈程度和合作机会。现有的化学和农业公司利用其下游渠道和规模优势整合生物基产品线，而专业生物技术公司则专注于酶工程、细胞培养优化和新型发酵渠道等平台能力，以抢占利基市场。这种双重性促使寻求互补能力的公司进行策略伙伴关係、授权协议和定向收购。

此外，投资环境持续支持那些能够展现可重复的流程和清晰的监管环境的公司。策略差异化通常源自于展现专有的製程技术、强大的智慧财产权组合以及能够降低大型买家商业化风险的供应链伙伴关係。合约开发和受託製造公司作为中间商，其角色日益凸显，使中小创新企业无需大量资本支出即可实现规模化发展。

卓越的营运、符合监管标准的品质体係以及能够展示检验的永续性指标，是主要企业通用成功的因素。那些兼具技术实力、强大的商业化路径和快速的客户互动能力的企业，往往在吸引策略合作伙伴和签订长期承购协议方面优于同业。

领导团队可以采取切实可行的优先行动，以降低商业化风险、优化营运并加速生物基工业解决方案的采用。

产业领导者应采取一系列切实可行的措施，将科学研究潜力转化为永续的商业性成果，同时管控监管、供应链和政策风险。首先，应优先考虑模组化和灵活的生产设计，以便快速调整原料投入和产品线，从而降低关税和原材料价格波动带来的风险。其次，应投资于製程强化和下游加工，以降低单位成本和环境影响，进而为终端用户提供兼具经济性和生态学效益的生物基替代产品。

第三，与价值链各环节（原料供应商、契约製造、品牌所有者等）建立伙伴关係，以加速市场进入并分担规模化生产的资金负担。第四，从一开始就将监管和永续性标准纳入产品开发蓝图，以缩短核准时间并满足买家对透明环境绩效的期望。此外，加强智慧财产权策略，保护製程创新，同时允许选择性地向互补型合作伙伴授权，以加速技术推广应用。

最后，我们将先进的分析和情境规划融入策略决策，使领导团队能够对供应链进行压力测试、评估关税方案，并确定本地投资的优先市场。透过结合营运灵活性、协作式商业化模式和严谨的监管规划，企业可以将前景广阔的技术转化为可复製、盈利的产品线。

采用严谨的混合方法研究途径，结合一手专家研究、技术文献综述和三角验证，以检验策略性洞见。

本研究整合了一手和二手资料，结合专家访谈、技术文献综述和跨职能三角验证，为白色生物技术的动态提供了一个可靠且经过验证的观点。一手资料包括对研发负责人、製程工程师、采购人员和法规专家的结构化访谈，他们提供了关于技术成熟度、供应链限制因素和客户采纳驱动因素的定性见解。此外，我们还进行了实地考察和检验研讨会，以确保我们对技术细节的解读与实际应用相符。

为确保技术论点和政策解读基于检验的资讯来源，我们进行了二次研究，检索了同行评审期刊、行业标准指南、专利申请以及公开的监管文件。我们运用数据三角测量技术，整合不同的数据，并突显不同产品领域与地区之间的一致性模式。品质保证措施包括独立专家评审和对主题结论的反覆最后覆核，以减少偏差并提高研究结果的可重复性。

调查方法以伦理考量和透明度指南，所有机密资讯均已匿名化处理，专有资讯则依约定的保密条款处理。这种混合方法为白色生物技术领域的领导者提供了可靠的证据基础，以支持其策略规划和业务优先事项的确定。

关键策略结论：综合考量对白色生物技术创新商业化至关重要的技术、监管和营运槓桿

结论摘要了决策者在不断变化的生物技术领域中需要关注的核心要点：技术带来的效率提升、监管和永续性驱动因素以及外部政策行动共同决定了哪些提案能够成功推广。将卓越技术与灵活的生产布局和完善的永续性理念相结合的企业将更有利于创造持久价值。此外，关税政策的变化和区域政策差异要求企业具备策略弹性和积极主动的供应链管理能力，才能保持竞争力。

未来成功发展的关键在于：产品开发与客户特定的性能指标保持一致，确保可靠的原材料供应，并展现出能够引起监管机构和采购方共鸣的、可信赖的生命週期效益。策略合作、选择性的垂直整合以及严谨的智慧财产权管理，是企业弥合技术示范与商业性应用之间差距的有力工具。最终，将生物创新视为涵盖采购、监管策略和客户参与等更广泛系统转型的一部分的相关人员，将加速技术应用，并建立更具韧性的经营模式。

这种整合应该有助于领导团队确定投资的优先顺序、建立伙伴关係，并制定营运蓝图，将科学能力转化为可扩展、可持续的商业性成果。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 利用工程微生物群落将木质纤维素生物质转化为永续化学品的规模化生产面临挑战
  • 透过基于 CRISPR 的代谢通道优化技术，实现高产量特异性酵素的生物加工。
  • 在工业发酵过程中采用连续在线监测感测器进行即时品管
  • 利用可再生原料的微生物发酵开发生物基生物分解性塑胶
  • 将人工智慧驱动的反应器设计融入生产过程，可提高酵素生产的效率并减少停机时间。
  • 工业生物技术领域中新型基因工程微生物菌株核准的监管协调工作
  • 石油化学巨头与生物技术Start-Ups合作，开发与引擎相容性极佳的直接替代型生质燃料。
  • 在多产品生物炼製厂中，透过生物质残渣流的工业共生实现循环经济模式
  • 扩大藻类碳捕获平台规模并将其整合到生质燃料和高价值产品生产策略中
  • 投资模组化、可携式可携式装置，用于快速现场生产精细化学品和生物製药前体

第六章美国关税的累积影响，2025年

第七章 人工智慧的累积影响，2025年

8. 白色生物技术市场（依产品类型划分）

  • 胺基酸
    • L-离胺酸
    • L-苏胺酸
  • 生质燃料
    • 生质柴油
    • 生质乙醇
    • 沼气
  • 生物製药
    • 单株抗体
    • 重组蛋白
    • 疫苗
  • 生质塑胶
    • PHA
    • PLA
  • 酵素
    • 工业酵素
    • 特殊酵素
  • 维他命
    • 维生素C
    • 维生素E

9. 白色生物技术市场（依技术划分）

  • 细胞培养技术
    • 动物细胞培养
    • 微生物细胞培养
  • 下游加工
    • 层析法
    • 烘干
    • 滤
  • 酵素技术
    • 酵素工程
    • 酵素固定化
  • 发酵技术
    • 固体发酵
    • 深层发酵
  • 基因工程技术
    • CRISPR技术
    • 重组DNA技术

第十章：白色生物技术市场（依应用领域划分）

  • 饮食
    • 麵包店
    • 饮料
    • 糖果甜点
    • 乳製品
  • 家居护理和工业清洁
    • 清洁剂
    • 清洁剂
  • 石油和天然气
    • 生物修復
    • 提高采收率
  • 纸浆和造纸
    • 纸张涂层
    • 纸浆漂白
  • 纺织品和皮革
    • 织物加工
    • 皮革加工

第十一章 白色生物技术市场（以最终用户划分）

  • 农业
    • 肥料
    • 杀虫剂
  • 动物饲料
    • 水产饲料
    • 家禽饲料
  • 化学品
    • 大宗化学品
    • 特种化学品
  • 化妆品
    • 护髮
    • 护肤
  • 製药
    • 生技药品
    • 小分子药物

第十二章：原料类白色生物技术市场

  • 木薯
  • 玉米
  • 甘蔗
  • 小麦

第十三章：各区域白色生物技术市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 白色生物技术市场（依集团划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 各国白色生物技术市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Novozymes A/S
    • DuPont de Nemours, Inc.
    • Koninklijke DSM NV
    • BASF SE
    • Archer Daniels Midland Company
    • Cargill, Incorporated
    • Evonik Industries AG
    • Roquette Freres SA
    • Corbion NV
    • Chr. Hansen Holding A/S
Product Code: MRR-710B1F0AC6A9

The White Biotechnology Market is projected to grow by USD 301.53 billion at a CAGR of 3.28% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 232.78 billion
Estimated Year [2025] USD 240.45 billion
Forecast Year [2032] USD 301.53 billion
CAGR (%) 3.28%

A concise yet comprehensive orientation to the evolving white biotechnology landscape that frames technical progress, regulatory shifts, and strategic imperatives

The white biotechnology sector is at an inflection point where innovation, sustainability, and evolving regulation intersect to reshape industrial value chains. This introduction synthesizes the forces that are redefining how biological processes and bio-based products are developed, produced, and commercialized across diverse industries. As industrial stakeholders increasingly prioritize low-carbon solutions and circularity, the role of fermentation, enzyme catalysis, and genetic engineering has expanded beyond niche applications into mainstream manufacturing strategies.

Throughout this summary, attention is placed on both technological advances and shifting market dynamics that influence decision-making for manufacturers, processors, and end users. Advances in cell culture and enzyme technology are improving process yields and enabling new product classes, while downstream processing innovations lower purification costs and reduce environmental footprints. Concurrently, regulatory frameworks and public procurement preferences are elevating sustainability credentials as a competitive differentiator.

The introduction sets the stage for deeper analysis by outlining the key themes that follow: transformative shifts in technology and policy, the implications of tariff actions, segmentation-driven insights across product and application categories, regional performance nuances, and practical recommendations for leaders seeking to convert scientific capability into commercial advantage.

How molecular innovations, process intensification, and sustainability imperatives are reorganizing industrial value chains and commercial priorities in white biotechnology

White biotechnology is undergoing transformative shifts driven by rapid advances in molecular biology, process intensification, and sustainability mandates that are altering industrial priorities across multiple sectors. Synthetic biology and CRISPR-enabled engineering are accelerating the development of bespoke microbes and enzymes, thereby expanding the palette of producible biochemicals and enabling resource-efficient pathways. As a result, companies are increasingly pursuing integrated bioprocess platforms that combine upstream fermentation, precision enzyme catalysis, and streamlined downstream processing to shorten development cycles and improve unit economics.

Concurrently, demand-side shifts are elevating biologically derived products in food, materials, and pharmaceuticals. Buyers are placing higher value on traceability, lower lifecycle emissions, and functional performance that matches or exceeds conventional alternatives. These expectations are catalyzing cross-sector partnerships between ingredient producers, formulators, and brand owners seeking to co-develop applications that can scale commercially. In addition, capital allocation patterns are tilting toward firms that demonstrate both technological differentiation and clear pathways to regulatory compliance, prompting consolidation and strategic alliances.

Taken together, these transformative shifts are converting laboratory breakthroughs into industrial options at pace, necessitating adaptive strategies that reconcile scientific potential with supply chain resilience and regulatory realities.

The ripple effects of United States tariff adjustments reshaping sourcing strategies, production footprints, and supply chain resilience in white biotechnology

Tariff policy decisions in the United States have introduced a new layer of commercial complexity for producers, suppliers, and buyers in the white biotechnology ecosystem. The cumulative impacts observed in 2025 reflect adjustments across import costs, supply chain sourcing strategies, and pricing dynamics that require enterprises to revisit procurement and manufacturing footprints. Higher duties on select bio-derived inputs and intermediate goods have prompted some firms to accelerate local production initiatives, repatriate critical processing steps, or seek alternative feedstock routes that reduce exposure to tariffed commodities.

As a consequence, companies with flexible process designs and modular manufacturing capabilities have been better positioned to mitigate added cost pressures through rapid reconfiguration of ingredient sourcing. Downstream processors and contract development and manufacturing organizations have seen an increased demand for localization services as clients prioritize tariff risk mitigation and continuity of supply. In parallel, purchasers have intensified supplier qualification criteria to incorporate tariff sensitivity analysis, total landed cost assessments, and contingency sourcing plans.

Importantly, the tariff-driven rebalancing has also amplified interest in vertical integration for actors that can secure feedstock availability and control conversion steps. Firms are therefore evaluating strategic investments that promote raw material resilience, reduce logistics exposure, and preserve margins while maintaining compliance with evolving trade and customs regimes.

Segment-specific intelligence revealing how product categories, processing technologies, applications, end users, and feedstock choices create distinct strategic pathways

Insightful segmentation reveals differentiated opportunity zones across product types, technologies, applications, end users, and feedstock choices that influence both R&D priorities and commercial approaches. Product-level distinctions span amino acids, biofuels, biopharmaceuticals, bioplastics, enzymes, and vitamins, with subcategories such as L-Lysine and L-Threonine, biodiesel and bioethanol, monoclonal antibodies and recombinant proteins, PHA and PLA bioplastics, industrial versus specialty enzymes, and vitamin C and vitamin E each presenting unique technical and regulatory considerations. These product variances shape downstream processing complexity, regulatory pathways, and customer adoption timelines.

On the technology axis, differentiation emerges between cell culture platforms, downstream separation science, enzyme engineering and immobilization, fermentation modalities, and genetic engineering approaches including CRISPR and recombinant DNA techniques. Each technological domain offers distinct levers for cost reduction, yield enhancement, and functionality expansion, and firms often combine multiple technologies to create competitive barriers. Application-driven segmentation covers food and beverages, household care and industrial cleaning, oil and gas interventions, paper and pulp treatments, and textiles and leather processing, where use-case specificity defines formulation requirements and performance benchmarks.

End-user distinctions among agriculture, animal feed, chemical manufacturing, cosmetics, and pharmaceuticals further refine commercialization strategies, as customers in each sector prioritize different attributes-such as shelf stability for cosmetics, regulatory dossiers for pharmaceuticals, or nutrient density for animal feed. Finally, feedstock selection among cassava, corn, sugarcane, and wheat influences sustainability narratives, supply chain risk profiles, and cost structures, underscoring the need for integrated product-to-feedstock planning that aligns technical feasibility with commercial demand.

A cross-regional synthesis of adoption patterns, regulatory environments, and operational priorities that govern white biotechnology strategies across global hubs

Regional dynamics demonstrate varied trajectories for adoption, production capacity, and policy environment across the Americas, Europe, Middle East & Africa, and Asia-Pacific, with each geography presenting distinct commercial contours and operational considerations. In the Americas, strengths in downstream processing innovation, venture capital activity, and strong institutional demand are contrasted with localized feedstock dependencies and trade policy sensitivities that shape sourcing decisions. These dynamics favor firms that can combine technical differentiation with agile supply chain configurations.

The Europe, Middle East & Africa region emphasizes regulatory rigor, sustainability reporting, and circular economy policies that create opportunities for bio-based materials and greener manufacturing processes. Producers and technology suppliers operating in this region must navigate harmonized regulatory frameworks and growing customer demand for transparency, which rewards firms that can demonstrate verifiable lifecycle improvements and compliance readiness. In contrast, the Asia-Pacific region is characterized by scale-driven manufacturing capabilities, rapidly expanding domestic demand for bio-derived ingredients, and diverse feedstock availability, encouraging investments in large-scale fermentation infrastructure and regional partnerships to meet both domestic and export-oriented needs.

Taken together, these regional contrasts indicate that successful actors tailor their market entry and growth strategies to local regulatory expectations, feedstock ecosystems, and customer priorities while retaining the flexibility to redeploy capabilities across geographies as commercial conditions evolve.

How competitive dynamics, partnerships, and operational excellence among incumbents and innovators are shaping leadership in white biotechnology

Company-level dynamics in white biotechnology emphasize a mix of incumbent industrial players, specialized bioprocess innovators, and agile start-ups that together define competitive intensity and collaboration opportunities. Established chemical and agricultural firms are leveraging their downstream channels and scale to integrate bio-based product lines, while specialist biotechnology companies concentrate on platform capabilities such as enzyme engineering, cell culture optimization, and novel fermentation pathways to capture niche value pools. This duality has encouraged strategic partnerships, licensing arrangements, and targeted acquisitions as firms seek complementary capabilities.

In addition, the investment landscape continues to support companies that demonstrate reproducible process performance and clear regulatory strategies. Strategic differentiation frequently arises from proprietary process know-how, robust intellectual property portfolios, and demonstrated supply chain partnerships that de-risk commercialization for large buyers. Contract development and manufacturing organizations are increasingly relevant as intermediaries that enable smaller innovators to scale without requiring heavy capital outlays.

Operational excellence, quality systems alignment with regulatory standards, and the ability to articulate verifiable sustainability metrics are common success factors among leading companies. Firms that combine technical depth with strong commercialization pathways and responsive customer engagement tend to outperform peers in attracting strategic partners and long-term off-take agreements.

Practical and prioritized actions that leadership teams can implement to de-risk commercialization, optimize operations, and accelerate adoption of bio-based industrial solutions

Industry leaders should adopt a pragmatic suite of actions to translate scientific potential into durable commercial outcomes while managing regulatory, supply chain, and policy risks. First, prioritize modular and flexible manufacturing designs that allow rapid adaptation of feedstock inputs and product lines to mitigate tariff exposure and feedstock volatility. Second, invest in process intensification and downstream processing capabilities to reduce unit costs and environmental impact, thereby making bio-based alternatives economically and ecologically compelling for end users.

Third, develop targeted partnerships across the value chain, including feedstock suppliers, contract manufacturers, and brand owners, to accelerate market access and share the capital burden of scale-up. Fourth, integrate regulatory and sustainability criteria into product development roadmaps from day one to shorten approval times and meet buyer expectations for transparent environmental performance. Additionally, strengthen intellectual property strategies that protect process innovations while enabling selective licensing where complementary partners can accelerate adoption.

Finally, embed advanced analytics and scenario planning into strategic decision-making so that leadership teams can stress-test supply chains, evaluate tariff scenarios, and identify priority markets for localized investment. By combining operational flexibility, collaborative commercialization models, and disciplined regulatory planning, companies can convert promising technologies into repeatable, profitable product lines.

A rigorous mixed-methods research approach integrating primary expert engagement, technical literature review, and triangulation to validate strategic insights

This research synthesizes primary and secondary methods to deliver a robust and validated perspective on white biotechnology dynamics, combining expert interviews, technical literature review, and cross-sector triangulation. Primary inputs include structured interviews with R&D leaders, process engineers, procurement heads, and regulatory specialists who provided qualitative insights into technology maturation, supply chain constraints, and customer adoption drivers. These conversations were complemented by site visit observations and validation workshops that ensured interpretation of technical details aligned with real-world practice.

Secondary research encompassed peer-reviewed journals, industry standards guidance, patent filings, and publicly available regulatory documentation to ensure technical assertions and policy interpretations were grounded in verifiable sources. Data triangulation techniques were applied to reconcile differing inputs and to surface consistent patterns across product segments and geographies. Quality assurance steps included independent expert review and iterative cross-checking of thematic conclusions to reduce bias and strengthen reproducibility.

Ethical considerations and transparency guided the methodology, with confidential inputs anonymized and proprietary information handled under agreed non-disclosure terms. This mixed-methods approach provides leaders with a defensible evidence base for strategic planning and operational prioritization in white biotechnology.

Key strategic conclusions that synthesize technological, regulatory, and operational levers critical for commercializing white biotechnology innovations

The conclusion encapsulates the central takeaways for decision-makers navigating the evolving white biotechnology landscape: technology-enabled efficiency gains, regulatory and sustainability drivers, and external policy actions collectively determine which propositions will scale successfully. Organizations that combine technical excellence with adaptive manufacturing footprints and integrated sustainability narratives are best positioned to capture enduring value. Moreover, tariff developments and regional policy differences require strategic flexibility and proactive supply chain management to preserve competitiveness.

Looking ahead, success will hinge on the ability to align product development with customer-specific performance metrics, to secure reliable feedstock channels, and to demonstrate credible lifecycle benefits that resonate with regulators and purchasers alike. Strategic collaborations, selective vertical integration, and disciplined intellectual property management will be powerful tools for firms seeking to bridge technical demonstration and commercial adoption. Ultimately, stakeholders who treat biological innovation as part of a broader systems transformation-incorporating procurement, regulatory strategy, and customer engagement-will accelerate adoption and create more resilient business models.

This synthesis should help leadership teams prioritize investments, structure partnerships, and design operational roadmaps that convert scientific capability into scalable, sustainable commercial outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Scale-up challenges in lignocellulosic biomass conversion using engineered microbial consortia for sustainable chemical production
  • 5.2. Advancements in CRISPR-enabled metabolic pathway optimization for high-yield bioprocessing of specialty enzymes
  • 5.3. Adoption of continuous inline monitoring sensors for real-time quality control in industrial fermentation processes
  • 5.4. Development of bio-based biodegradable plastics through microbial fermentation of renewable feedstocks
  • 5.5. Integration of AI-driven bioreactor design to enhance productivity and reduce downtime in enzyme manufacturing
  • 5.6. Regulatory harmonization efforts for approving novel genetically modified microbial strains in industrial biotechnology
  • 5.7. Collaboration between petrochemical giants and biotech startups for co-development of drop-in biofuels with optimal engine compatibility
  • 5.8. Implementation of circular economy models through industrial symbiosis of biomass residual streams in multi-product biorefineries
  • 5.9. Scale-up of algae-based carbon capture platforms coupled with biofuel and high-value co-product generation strategies
  • 5.10. Investment in modular portable biomanufacturing units for rapid on-site production of fine chemicals and biopharmaceutical precursors

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. White Biotechnology Market, by Product Type

  • 8.1. Amino Acids
    • 8.1.1. L-Lysine
    • 8.1.2. L-Threonine
  • 8.2. Biofuels
    • 8.2.1. Biodiesel
    • 8.2.2. Bioethanol
    • 8.2.3. Biogas
  • 8.3. Biopharmaceuticals
    • 8.3.1. Monoclonal Antibodies
    • 8.3.2. Recombinant Proteins
    • 8.3.3. Vaccines
  • 8.4. Bioplastics
    • 8.4.1. Pha
    • 8.4.2. Pla
  • 8.5. Enzymes
    • 8.5.1. Industrial Enzymes
    • 8.5.2. Specialty Enzymes
  • 8.6. Vitamins
    • 8.6.1. Vitamin C
    • 8.6.2. Vitamin E

9. White Biotechnology Market, by Technology

  • 9.1. Cell Culture Technology
    • 9.1.1. Animal Cell Culture
    • 9.1.2. Microbial Cell Culture
  • 9.2. Downstream Processing
    • 9.2.1. Chromatography
    • 9.2.2. Drying
    • 9.2.3. Filtration
  • 9.3. Enzyme Technology
    • 9.3.1. Enzyme Engineering
    • 9.3.2. Enzyme Immobilization
  • 9.4. Fermentation Technology
    • 9.4.1. Solid-State Fermentation
    • 9.4.2. Submerged Fermentation
  • 9.5. Genetic Engineering Technology
    • 9.5.1. Crispr Technology
    • 9.5.2. Recombinant Dna Technology

10. White Biotechnology Market, by Application

  • 10.1. Food And Beverages
    • 10.1.1. Bakery
    • 10.1.2. Beverages
    • 10.1.3. Confectionery
    • 10.1.4. Dairy
  • 10.2. Household Care And Industrial Cleaning
    • 10.2.1. Cleaning Agents
    • 10.2.2. Detergents
  • 10.3. Oil And Gas
    • 10.3.1. Bioremediation
    • 10.3.2. Enhanced Oil Recovery
  • 10.4. Paper And Pulp
    • 10.4.1. Paper Coating
    • 10.4.2. Pulp Bleaching
  • 10.5. Textiles And Leather
    • 10.5.1. Fabric Treatment
    • 10.5.2. Leather Processing

11. White Biotechnology Market, by End User

  • 11.1. Agriculture
    • 11.1.1. Fertilizers
    • 11.1.2. Pesticides
  • 11.2. Animal Feed
    • 11.2.1. Aquaculture Feed
    • 11.2.2. Poultry Feed
  • 11.3. Chemical
    • 11.3.1. Bulk Chemicals
    • 11.3.2. Specialty Chemicals
  • 11.4. Cosmetics
    • 11.4.1. Haircare
    • 11.4.2. Skincare
  • 11.5. Pharmaceuticals
    • 11.5.1. Biologics
    • 11.5.2. Small Molecule Drugs

12. White Biotechnology Market, by Raw Material

  • 12.1. Cassava
  • 12.2. Corn
  • 12.3. Sugarcane
  • 12.4. Wheat

13. White Biotechnology Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. White Biotechnology Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. White Biotechnology Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Novozymes A/S
    • 16.3.2. DuPont de Nemours, Inc.
    • 16.3.3. Koninklijke DSM N.V.
    • 16.3.4. BASF SE
    • 16.3.5. Archer Daniels Midland Company
    • 16.3.6. Cargill, Incorporated
    • 16.3.7. Evonik Industries AG
    • 16.3.8. Roquette Freres S.A.
    • 16.3.9. Corbion N.V.
    • 16.3.10. Chr. Hansen Holding A/S

LIST OF FIGURES

  • FIGURE 1. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY RAW MATERIAL, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY RAW MATERIAL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS WHITE BIOTECHNOLOGY MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA WHITE BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA WHITE BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA WHITE BIOTECHNOLOGY MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE WHITE BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST WHITE BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA WHITE BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC WHITE BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN WHITE BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC WHITE BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION WHITE BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS WHITE BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 WHITE BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO WHITE BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. WHITE BIOTECHNOLOGY MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. WHITE BIOTECHNOLOGY MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. WHITE BIOTECHNOLOGY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY AMINO ACIDS, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY AMINO ACIDS, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY AMINO ACIDS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY AMINO ACIDS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY AMINO ACIDS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY AMINO ACIDS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY AMINO ACIDS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY AMINO ACIDS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY L-LYSINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY L-LYSINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY L-LYSINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY L-LYSINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY L-LYSINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY L-LYSINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY L-THREONINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY L-THREONINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY L-THREONINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY L-THREONINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY L-THREONINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY L-THREONINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIOFUELS, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIOFUELS, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIOFUELS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIOFUELS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIOFUELS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIOFUELS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIOFUELS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIOFUELS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIODIESEL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIODIESEL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIODIESEL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIODIESEL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIODIESEL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIODIESEL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIOETHANOL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIOETHANOL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIOETHANOL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIOETHANOL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIOETHANOL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIOETHANOL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIOGAS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIOGAS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIOGAS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIOGAS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIOGAS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIOGAS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIOPHARMACEUTICALS, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIOPHARMACEUTICALS, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIOPHARMACEUTICALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIOPHARMACEUTICALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIOPHARMACEUTICALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIOPHARMACEUTICALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIOPHARMACEUTICALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIOPHARMACEUTICALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY RECOMBINANT PROTEINS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY RECOMBINANT PROTEINS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY RECOMBINANT PROTEINS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY RECOMBINANT PROTEINS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY RECOMBINANT PROTEINS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY RECOMBINANT PROTEINS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY VACCINES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY VACCINES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY VACCINES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY VACCINES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY VACCINES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY VACCINES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIOPLASTICS, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIOPLASTICS, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIOPLASTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIOPLASTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIOPLASTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIOPLASTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIOPLASTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIOPLASTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY PHA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY PHA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY PHA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY PHA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY PHA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY PHA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY PLA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY PLA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY PLA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY PLA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY PLA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY PLA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ENZYMES, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ENZYMES, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ENZYMES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ENZYMES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ENZYMES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ENZYMES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ENZYMES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ENZYMES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY INDUSTRIAL ENZYMES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY INDUSTRIAL ENZYMES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY INDUSTRIAL ENZYMES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY INDUSTRIAL ENZYMES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY INDUSTRIAL ENZYMES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY INDUSTRIAL ENZYMES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY SPECIALTY ENZYMES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY SPECIALTY ENZYMES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY SPECIALTY ENZYMES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY SPECIALTY ENZYMES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY SPECIALTY ENZYMES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY SPECIALTY ENZYMES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY VITAMINS, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY VITAMINS, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY VITAMINS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY VITAMINS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY VITAMINS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY VITAMINS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY VITAMINS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY VITAMINS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY VITAMIN C, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY VITAMIN C, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY VITAMIN C, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY VITAMIN C, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY VITAMIN C, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY VITAMIN C, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY VITAMIN E, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY VITAMIN E, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY VITAMIN E, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY VITAMIN E, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY VITAMIN E, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY VITAMIN E, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY CELL CULTURE TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY CELL CULTURE TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY CELL CULTURE TECHNOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY CELL CULTURE TECHNOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY CELL CULTURE TECHNOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY CELL CULTURE TECHNOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY CELL CULTURE TECHNOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY CELL CULTURE TECHNOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ANIMAL CELL CULTURE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ANIMAL CELL CULTURE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ANIMAL CELL CULTURE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ANIMAL CELL CULTURE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ANIMAL CELL CULTURE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ANIMAL CELL CULTURE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY MICROBIAL CELL CULTURE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY MICROBIAL CELL CULTURE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY MICROBIAL CELL CULTURE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY MICROBIAL CELL CULTURE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY MICROBIAL CELL CULTURE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY MICROBIAL CELL CULTURE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY DOWNSTREAM PROCESSING, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY DOWNSTREAM PROCESSING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY DOWNSTREAM PROCESSING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY DOWNSTREAM PROCESSING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY DOWNSTREAM PROCESSING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY DOWNSTREAM PROCESSING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY DOWNSTREAM PROCESSING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY CHROMATOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY CHROMATOGRAPHY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY CHROMATOGRAPHY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY CHROMATOGRAPHY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY CHROMATOGRAPHY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY CHROMATOGRAPHY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY DRYING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY DRYING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY DRYING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY DRYING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY DRYING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY DRYING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY FILTRATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY FILTRATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY FILTRATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY FILTRATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY FILTRATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY FILTRATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ENZYME TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ENZYME TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ENZYME TECHNOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ENZYME TECHNOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ENZYME TECHNOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ENZYME TECHNOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ENZYME TECHNOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ENZYME TECHNOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ENZYME ENGINEERING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ENZYME ENGINEERING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ENZYME ENGINEERING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ENZYME ENGINEERING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ENZYME ENGINEERING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ENZYME ENGINEERING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ENZYME IMMOBILIZATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ENZYME IMMOBILIZATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ENZYME IMMOBILIZATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ENZYME IMMOBILIZATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ENZYME IMMOBILIZATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ENZYME IMMOBILIZATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY FERMENTATION TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY FERMENTATION TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY FERMENTATION TECHNOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY FERMENTATION TECHNOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY FERMENTATION TECHNOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY FERMENTATION TECHNOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY FERMENTATION TECHNOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY FERMENTATION TECHNOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY SOLID-STATE FERMENTATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY SOLID-STATE FERMENTATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY SOLID-STATE FERMENTATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY SOLID-STATE FERMENTATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY SOLID-STATE FERMENTATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY SOLID-STATE FERMENTATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY SUBMERGED FERMENTATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY SUBMERGED FERMENTATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY SUBMERGED FERMENTATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY SUBMERGED FERMENTATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY SUBMERGED FERMENTATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY SUBMERGED FERMENTATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING TECHNOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING TECHNOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING TECHNOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING TECHNOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING TECHNOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING TECHNOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY CRISPR TECHNOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY CRISPR TECHNOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY CRISPR TECHNOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY CRISPR TECHNOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY CRISPR TECHNOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY CRISPR TECHNOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY RECOMBINANT DNA TECHNOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY RECOMBINANT DNA TECHNOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY RECOMBINANT DNA TECHNOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY RECOMBINANT DNA TECHNOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY RECOMBINANT DNA TECHNOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY RECOMBINANT DNA TECHNOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY FOOD AND BEVERAGES, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY FOOD AND BEVERAGES, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY FOOD AND BEVERAGES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY FOOD AND BEVERAGES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY FOOD AND BEVERAGES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY FOOD AND BEVERAGES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY FOOD AND BEVERAGES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY FOOD AND BEVERAGES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BAKERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BAKERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BAKERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BAKERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 261. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BAKERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 262. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BAKERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BEVERAGES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BEVERAGES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 265. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BEVERAGES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 266. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BEVERAGES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 267. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BEVERAGES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 268. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BEVERAGES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 269. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY CONFECTIONERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 270. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY CONFECTIONERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 271. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY CONFECTIONERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 272. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY CONFECTIONERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 273. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY CONFECTIONERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 274. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY CONFECTIONERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 275. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY DAIRY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 276. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY DAIRY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 277. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY DAIRY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 278. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY DAIRY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 279. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY DAIRY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 280. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY DAIRY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 281. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY HOUSEHOLD CARE AND INDUSTRIAL CLEANING, 2018-2024 (USD MILLION)
  • TABLE 282. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY HOUSEHOLD CARE AND INDUSTRIAL CLEANING, 2025-2032 (USD MILLION)
  • TABLE 283. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY HOUSEHOLD CARE AND INDUSTRIAL CLEANING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 284. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY HOUSEHOLD CARE AND INDUSTRIAL CLEANING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 285. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY HOUSEHOLD CARE AND INDUSTRIAL CLEANING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 286. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY HOUSEHOLD CARE AND INDUSTRIAL CLEANING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 287. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY HOUSEHOLD CARE AND INDUSTRIAL CLEANING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 288. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY HOUSEHOLD CARE AND INDUSTRIAL CLEANING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 289. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY CLEANING AGENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 290. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY CLEANING AGENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 291. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY CLEANING AGENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 292. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY CLEANING AGENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 293. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY CLEANING AGENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 294. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY CLEANING AGENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 295. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY DETERGENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 296. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY DETERGENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 297. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY DETERGENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 298. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY DETERGENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 299. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY DETERGENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 300. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY DETERGENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 301. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY OIL AND GAS, 2018-2024 (USD MILLION)
  • TABLE 302. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY OIL AND GAS, 2025-2032 (USD MILLION)
  • TABLE 303. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY OIL AND GAS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 304. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY OIL AND GAS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 305. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY OIL AND GAS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 306. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY OIL AND GAS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 307. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY OIL AND GAS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 308. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY OIL AND GAS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 309. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIOREMEDIATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 310. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIOREMEDIATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 311. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIOREMEDIATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 312. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIOREMEDIATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 313. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIOREMEDIATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 314. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY BIOREMEDIATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 315. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ENHANCED OIL RECOVERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 316. GLOBAL WHITE BIOTECHNOLOGY MARKET SIZE, BY ENHANCED OIL RECOVERY, BY REGION, 2025-2032 (U